GI Illness

Feature Article

COVID-19: Atypical GI Presentations

There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.

Latest News

GI Illness

Prediction Model May Offer Better Intervention for CRE Infection After Liver Transplantation

Sweta Gupta

Investigators conducted a retrospective, multinational cohort study with the intent to develop a prediction model for carbapenem-resistant Enterobacteriaceae infection after liver transplantation.

GI Illness

Small Intestinal Bacterial Overgrowth Linked to Poor Outcomes in Patients With Heart Failure

Colby Stong

Investigators sought to determine the prevalence of small intestinal bacterial overgrowth and establish its prognostic value in patients with heart failure.

GI Illness

Leukocytosis Is Not an Independent Predictor of Clostridium Difficile

Sweta Gupta

Researchers reviewed data of 16,568 consecutive patients from 4 hospitals over 4 years to determine if leukocytosis correlated with a positive C difficile NAAT results.

COVID19

COVID-19 Pandemic Leads to Decrease in GI Patient Encounters and New Diagnoses of GI Cancers and Procedures

Colby Stong

Investigators analyzed the impact of the COVID-19 pandemic on number of GI procedures performed and new cancer diagnoses.

General Infectious Disease

Association Between Helicobacter pylori Infection and Chronic Kidney Disease

Emily Pond

Investigators evaluated the relationship among Helicobacter pylori infection, atrophic gastritis, and chronic kidney disease.

General Infectious Disease

Assessment of Helicobacter pylori Antibody Type on Serum Gastric Function

Vincent Soreca

Researchers assessed the effects of different H pylori infections on distribution of histopathological characteristics and items of serum gastric function.

GI Illness

Socioeconomics, Not Pathogens, Responsible for Children’s Neurodevelopment

Jessica Nye, PhD

The investigators hypothesized that pathogens that cause diarrhea would be negatively associated with both growth and neurodevelopment.

Clostridioides Difficile

Overcoming Current Challenges in the Development of Microbiome Drugs

Jessica Nye, PhD

To develop microbiome drugs, scientists will need to address challenges in safety, uniformity, and delivery.

Hepatitis

High Prevalence of HCV Infection in MSM Regardless of HIV Status

Estie Mermelstein, MSN, FNP-BC

The researchers’ objective was to determine the prevalence of HCV antibodies among MSM with and without HIV, as well as factors associated with HCV infection among MSM.

GI Illness

Extreme Gradient Boosting Shows Promise for Predicting Risk for Gastric Cancer Development After Helicobacter pylori Eradication

Vincent Soreca

A team of investigators explored the ability of different machine learning models to predict the risk of gastric cancer development in patients who had undergone eradication of Helicobacter pylori infection.

GI Illness

Helicobacter pylori Eradication Associated With Reduced Risk of Dyslipidemia

Vincent Soreca

A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.

Hepatitis

Hepatic Steatosis Associated With Lower Risks in Chronic Hepatitis B

Sweta Gupta

This study’s goal was to study the effect of fatty liver on the incidence of cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in patients with chronic hepatitis B.

COVID19

Rate of Severe GI Complications Found to Be Low in Patients Hospitalized With COVID-19

Jessica Nye, PhD

Investigators assessed the rate of severe gastrointestinal complications in patients hospitalized with COVID-19 across 36 medical centers in the United States and Canada.

COVID19

Significant Decline in IBD Diagnoses and Related Procedures Seen During COVID-19 Pandemic in the Netherlands

Emily Pond

Investigators compared the rates of inflammatory bowel disease (IBD) diagnoses made and IBD-related procedures performed during the COVID-19 pandemic with pre-pandemic rates.

GI Illness

Severity Score for Pediatric Shigellosis and Implications for Vaccine Trials

Bradley van Paridon

Study authors compared characteristics of moderate to severe diarrhea between children with culture positive Shigella and culture-negative, qPCR-attributable Shigella and derived a new clinical severity score.

GI Illness

No Clinical Benefit With Double Anaerobic Therapy for Intra-Abdominal Infections

Sweta Gupta

Double anaerobic therapy with piperacillin/tazobactam plus metronidazole was compared to piperacillin/tazobactam alone to manage patients with intra-abdominal infections.

COVID19

COVID-19: GI Patients, Providers Report High Satisfaction With Telehealth

Colby Stong

Telehealth use in gastroenterology has significantly increased during the COVID-19 pandemic, with a high level of satisfaction among both patients and providers.

COVID19

Digestive Manifestations Appear to Be Mild in Patients Hospitalized With COVID-19

Virginia A. Schad, PharmD, RPh

Emerging evidence indicates that gastrointestinal and hepatic manifestations may play an important role in COVID-19, but their prevalence and significance remain unknown.